The NCI Outstanding Investigator Award (R35)

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Outstanding Investigator Award (OIA) supports investigators with outstanding records of productivity in cancer research by providing extended funding stability and encouraging investigators to continue or embark on projects of unusual potential in cancer research. The OIA provides up to $600,000 in direct costs per year for 7 years, allowing substantial time for funded investigators to take greater risks and be more adventurous in their research.

Applications must be submitted by institutions that have nominated a Principal Investigator (PI) with outstanding productivity in cancer research as a recipient of NCI grant(s) for at least the past 5 years. The PI will be expected to commit at least 6 calendar months effort to the OIA; the Institution will be expected to commit at least 20% salary support.

The Outstanding Investigator Award (R35)

NCI established the Outstanding Investigator Award (R35) in 2014 for principal investigators who have achieved significant research accomplishments. Featured in this video is Holly Prigerson, Ph.D., of Weill Cornell Medicine, who is among the first group of 62 researchers to receive the award.

  • Updated: July 7, 2017